Violich Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Violich Capital Management, Inc.

$769 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$73.27 - $83.09 $185,006 - $209,802	2,525 New	2,525 $205,000
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $160,474 - $230,385	2,575 New	2,575 $221,000
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $840,844 - $954,374	-12,960 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $940,891 - $1.02 Million	-13,900 Reduced 51.75%	12,960 $905,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $31,735 - $34,675	-500 Reduced 1.83%	26,860 $1.85 Million
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $30,000 - $34,230	-500 Reduced 1.79%	27,360 $1.77 Million
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $19,827 - $22,592	-350 Reduced 1.24%	27,860 $1.62 Million
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $111,780 - $140,544	-1,800 Reduced 6.0%	28,210 $1.78 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $14,468 - $16,800	-200 Reduced 0.66%	30,010 $2.31 Million
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $97,076 - $124,341	-1,550 Reduced 4.88%	30,210 $2.26 Million
Q4 2019 Jan 16, 2020	SELL	$61.62 - $67.78 $215,670 - $237,230	-3,500 Reduced 9.93%	31,760 $2.06 Million
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $109,392 - $120,750	-1,750 Reduced 4.73%	35,260 $2.24 Million
Q2 2019 Jul 22, 2019	SELL	$61.87 - $69.38 $470,521 - $527,634	-7,605 Reduced 17.05%	37,010 $0
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $192,279 - $215,403	-3,075 Reduced 6.45%	44,615 $2.9 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $2.17 Million - $2.83 Million	-35,870 Reduced 42.93%	47,690 $2.98 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $59,946 - $66,371	-841 Reduced 1.0%	83,560 $6.45 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $37,306 - $43,516	575 Added 0.69%	84,401 $5.98 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $36,420 - $44,400	-500 Reduced 0.59%	83,826 $6.32 Million
Q4 2017 Mar 01, 2018	SELL	$71.15 - $83.52 $185,345 - $217,569	-2,605 Reduced 3.0%	84,326 $6.04 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $118,909 - $140,940	1,649 Added 1.93%	86,931 $7.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	85,282	85,282 $0

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.

Account